Works matching IS 13866346 AND DT 2025 AND VI 55 AND IP 2

Results: 16
    1
    2
    3

    Hepatolithiasis pathogenesis update.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 168, doi. 10.1111/hepr.14153
    By:
    • Lu, Wei;
    • Li, Zhi‐Yuan;
    • Yang, Zhi‐Ming;
    • Hao, Jing‐Cheng
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Distribution of Fibrosis‐4 index and vibration‐controlled transient elastography‐derived liver stiffness measurement for patients with metabolic dysfunction‐associated steatotic liver disease in health check‐up.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 191, doi. 10.1111/hepr.14117
    By:
    • Ogawa, Yuji;
    • Tomeno, Wataru;
    • Imamura, Yasushi;
    • Baba, Masaru;
    • Ueno, Takato;
    • Kobayashi, Takashi;
    • Iwaki, Michihiro;
    • Nogami, Asako;
    • Kessoku, Takaomi;
    • Honda, Yasushi;
    • Notsumata, Kazuo;
    • Fujikawa, Hirotoshi;
    • Kaai, Megumi;
    • Imajo, Kento;
    • Kawanaka, Miwa;
    • Hyogo, Hideyuki;
    • Hisatomi, Mitsurou;
    • Takeuchi, Mamiko;
    • Hakamada, Taku;
    • Honda, Takashi
    Publication type:
    Article
    10
    11
    12

    Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapy.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 275, doi. 10.1111/hepr.14114
    By:
    • Kawamura, Yusuke;
    • Akuta, Norio;
    • Shindoh, Junichi;
    • Matsumura, Masaru;
    • Okubo, Satoshi;
    • Tominaga, Licht;
    • Yamamoto, Shigeki;
    • Eriksson, Yasuka;
    • Hosaka, Tetsuya;
    • Saitoh, Satoshi;
    • Sezaki, Hitomi;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Ikeda, Kenji;
    • Arase, Yasuji;
    • Hashimoto, Masaji;
    • Kozuka, Takuyo;
    • Kumada, Hiromitsu
    Publication type:
    Article
    13

    Prediction of hepatocellular carcinoma in patients with Fontan‐associated liver disease using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid magnetic resonance imaging.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 229, doi. 10.1111/hepr.14113
    By:
    • Yamamoto, Atsushi;
    • Nagao, Michinobu;
    • Inoue, Akihiro;
    • Nakao, Risako;
    • Sakai, Reiko;
    • Nishina, Yu;
    • Morita, Satoru;
    • Sakai, Akiko;
    • Kogiso, Tomomi;
    • Kaneko, Koichiro;
    • Tokushige, Katsutoshi;
    • Inai, Kei;
    • Sakai, Shuji;
    • Yamaguchi, Junichi
    Publication type:
    Article
    14
    15

    Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage‐associated molecular pattern analysis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 291, doi. 10.1111/hepr.14088
    By:
    • Ozaki, Tomomi;
    • Yumita, Sae;
    • Ogasawara, Sadahisa;
    • Fujiya, Makoto;
    • Tsuchiya, Takahiro;
    • Yoshino, Ryohei;
    • Sawada, Midori;
    • Akatsuka, Teppei;
    • Izai, Ryo;
    • Miwa, Chihiro;
    • Yonemoto, Takuya;
    • Fujimoto, Kentaro;
    • Unozawa, Hidemi;
    • Fujiwara, Kisako;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Nakamura, Masato
    Publication type:
    Article
    16

    Issue Information.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 161, doi. 10.1111/hepr.14064
    Publication type:
    Article